AstraZeneca names new U.S. chief
AstraZeneca PLC said today that Rich Fante has been appointed president of the company's U.S. business.
AstraZeneca PLC said today that Rich Fante has been appointed president of the company's U.S. business.
He takes over from Tony Zook, whose role was expanded after he was recently named president of MedImmune, the wholly owned biologics business for AstraZeneca PLC. Zook is CEO of AstraZeneca North America and head of global marketing.
London-based AstraZeneca has U.S. headquarters in Wilmington.
Fante had served as the company's vice president of brand strategy and portfolio operations.
American depositary shares of AstraZeneca were trading at $41.08, down $0.47 (1.13 percent), on the New York Stock Exchange.
Gerrit De Vynck and Miriam Waldvogel, Washington Post
Anne D'Innocenzio, Associated Press
Julia Carpenter, Washington Post
Gerrit De Vynck and Nitasha Tiku, Washington Post
Dorany Pineda, Associated Press
Mark Zandi, For The Inquirer
Francesca Regalado and Jonathan Wolfe, New York Times
Charlotte Keith, Spotlight PA
David McHugh and Emma Burrow, Associated Press
Review
Marc Levinson, Made By History
Mikella Schuettler, Associated Press
Mike Livingston
Marcus Hayes | Columnist
Dear Abby, Inquirer wire services
























